ACTUATE THERAPEUTICS, INC.
Nasdaq · CIK 0001652935 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-5.7M
Net Income
$-5.6M
Eps Basic
-0.24
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.7M | - | - |
| Net Income | $-5.6M | - | - |
| Eps Basic | -0.24 | - | - |
| Eps Diluted | -0.24 | - | - |
| Cash And Equivalents | $8.1M | - | - |
| Total Assets | $8.9M | - | - |
| Total Liabilities | $5.1M | - | - |
| Shareholders Equity | $3.8M | - | - |
| Operating Cash Flow | $-5.0M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | ACTUATE THERAPEUTICS, INC. | 2026-05-14 | 0001683168-26-003909 |
| 10-K | ACTUATE THERAPEUTICS, INC. | 2026-03-26 | 0001683168-26-002257 |
| 10-Q | ACTUATE THERAPEUTICS, INC. | 2025-11-13 | 0001683168-25-008323 |
| 10-Q | ACTUATE THERAPEUTICS, INC. | 2025-08-14 | 0001683168-25-006159 |